1. Home
  2. PDLB vs DCTH Comparison

PDLB vs DCTH Comparison

Compare PDLB & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ponce Financial Group Inc.

PDLB

Ponce Financial Group Inc.

HOLD

Current Price

$16.46

Market Cap

379.9M

Sector

N/A

ML Signal

HOLD

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$8.97

Market Cap

323.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDLB
DCTH
Founded
1960
1988
Country
United States
United States
Employees
216
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
379.9M
323.1M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
PDLB
DCTH
Price
$16.46
$8.97
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$22.00
AVG Volume (30 Days)
61.2K
410.1K
Earning Date
04-24-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
160.87
107.53
EPS
1.20
0.07
Revenue
N/A
N/A
Revenue This Year
N/A
$24.54
Revenue Next Year
N/A
$33.15
P/E Ratio
$13.83
$130.43
Revenue Growth
N/A
N/A
52 Week Low
$10.88
$8.12
52 Week High
$18.01
$18.23

Technical Indicators

Market Signals
Indicator
PDLB
DCTH
Relative Strength Index (RSI) 49.85 42.50
Support Level $16.38 $8.90
Resistance Level $17.29 $10.17
Average True Range (ATR) 0.31 0.32
MACD 0.03 -0.02
Stochastic Oscillator 45.45 8.22

Price Performance

Historical Comparison
PDLB
DCTH

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: